ログイン
言語:

WEKO3
  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



WEKO

One fine body…

WEKO

One fine body…

アイテム / Analysis of efficacy and safety in atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma 1)Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice 2)Risk factors for Early onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma / k9209_1

k9209_1

k9209_1.pdf
c7bb4204-c6ba-4f4b-b276-1a718746d7b3
https://hiroshima.repo.nii.ac.jp/record/2002295/files/k9209_1.pdf
ファイル ライセンス
k9209_1.pdf/k9209_1.pdf (203.5 kB) sha256 0264a5cd42b65b9c5a182ed40362dd4d38b404341432c4486cc0772f425f8a7c
公開日 2023-08-22
ファイル名 k9209_1.pdf
本文URL https://hiroshima.repo.nii.ac.jp/record/2002295/files/k9209_1.pdf
オブジェクトタイプ abstract
サイズ 198.7 KB
  • Version
  • Stats

Version Date Modified Object File Name File Size File Hash Value Contributor Name Show/Hide

Downloads

0

Plays

0

See details

Confirm

Powered by WEKO3

Powered by WEKO3